Risk Factors Affecting 5-Year Mortality in Incident  Hemodialysis Patients in the Black Sea Region of Türkiye

Erdem, Emre; Karataş, Ahmet; Ecder, Tevfik

doi:10.5152/turkjnephrol.2023.2246318

Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye

Emre ERDEM, (Dmed Samsun Diyaliz Kliniği, Samsun, Türkiye)

Ahmet KARATAŞ, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Samsun, Türkiye)

Süleyman Tevfik ECDER (Demiroğlu Bilim Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, İstanbul, Türkiye)

Turkish journal of nephrology (Online)

5 0

Yıl: 2023 Cilt: 32 Sayı: 3 Sayfa Aralığı: 221 - 227 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2023.2246318 İndeks Tarihi: 24-07-2023

Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye

Öz:

Objective: This study aimed to investigate the risk factors for all-cause mortality in incident hemodialysis patients during 5 years of the follow-up period. Methods: The study was conducted with 163 incident hemodialysis patients in the Black Sea region of Turkey. The patients were followed up for up to 5 years. The Cox proportional hazards regression analysis was used to detect the independent risk factors that affect mortality. Results: The median duration of follow-up was 50 (25-60) months. A total of 73 (44.8%) patients died during the 5 years of the follow-up period. The 5- year survival was 52%. Age ≥ 65 years [hazard ratio (95% CI): 1.917 (1.068-3.444); P = .029], use of a central venous catheter [hazard ratio (95% CI): 4.136 (2.338-7.319); P < .0001], serum albumin < 3.5 g/dL [hazard ratio (95% CI): 3.689 (1.876-7.257); P < .0001], corrected calcium < 8.4 mg/dL [hazard ratio (95% CI): 2.219 (1.132-4.351); P = .020], parathyroid hormone < 150 pg/mL [hazard ratio (95% CI): 2.243 (1.048-4.803); P = .037], uric acid > 7 mg/dL [hazard ratio (95% CI): 2.386 (1.154-4.933); P = .019], hemoglobin < 10 g/dL [hazard ratio (95% CI): 2.404 (1.280-4.515); P = .006], and transferrin saturation < 20% [hazard ratio (95% CI): 2.215 (1.102-4.453); P = .026] were identified as independent risk factors for mortality. Conclusion: Advanced age, use of a central venous catheter, hypocalcemia, hypoalbuminemia, hyperuricemia, adynamic bone disease, hemoglobin < 10 g/dL, and transferrin saturation < 20% are associated with an increased all-cause mortality risk in incident hemodialysis patients.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782-1789. [CrossRef]
2. Erdogmus S, Kaymakamtorunları F. Factors associated with mor tality in maintenance hemodialysis patients: a single-center data from east Anatolian region of Turkey. J Ankara Univer Facul Med. 2020;73(3):239-246.
3. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P. Mark ers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis. 1995;26(1):209-219. [CrossRef]
4. Ossareh S, Farrokhi F, Zebarjadi M. Survival of patients on hemo dialysis and predictors of mortality: a single-centre analysis of time-dependent factors. Iran J Kidney Dis. 2016;10(6):369-380.
5. Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Trans plant. 2018;33(suppl_3):iii28-iii34. [CrossRef]
6. Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia manage ment and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(1):94- 111. [CrossRef]
7. Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phos phate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948-1955. [CrossRef]
8. Goldwasser P, Mittman N, Antignani A, et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993;3(9):1613-1622. [CrossRef]
9. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31(6):997-1006. [CrossRef]
10. Erdem E, Karatas A, Ecder T. The relationship between serum fer ritin levels and 5-year all-cause mortality in hemodialysis patients. Blood Purif. 2022;51(1):55-61. [CrossRef]
11. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnu trition-inflammation score is correlated with morbidity and mor tality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251-1263. [CrossRef]
12. Wakasugi M, Kawamura K, Yamamoto S, Kazama JJ, Narita I. High mortality rate of infectious diseases in dialysis patients: a com parison with the general population in Japan. Ther Apher Dial. 2012;16(3):226-231. [CrossRef]
13. Wasse H. Catheter-related mortality among ESRD patients. Semin Dial. 2008;21(6):547-549. [CrossRef]
14. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620-626. [CrossRef]
15. Robinson BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014;85(1):158-165. [CrossRef]
16. Sato M, Hanafusa N, Tsuchiya K, Kawaguchi H, Nitta K. Impact of transferrin saturation on all-cause mortality in patients on main tenance hemodialysis. Blood Purif. 2019;48(2):158-166. [CrossRef]
17. Kuragano T, Joki N, Hase H, et al. Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascu lar and cardiovascular disease and death in maintenance hemo dialysis patients. PLoS One. 2020;15(9):e0236277. [CrossRef]
18. KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(4):279-335.
19. Yang Y, Qin X, Li Y, et al. Relationship between serum uric acid and mortality risk in hemodialysis patients: a multicenter prospective cohort study. Am J Nephrol. 2020;51(10):823-832. [CrossRef]
20. Taniguchi M, Fukagawa M, Fujii N, et al. Serum phosphate and cal cium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial. 2013;17(2):221-228. [CrossRef]
21. National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884-930. [CrossRef]
22. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1-59. [CrossRef]
23. Daugirdas JT. Second generation logarithmic estimates of single pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205-1213. [CrossRef]
24. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60(4):1443-1451. [CrossRef]
25. Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The survival benefit of "fistula first, catheter last" in hemodialysis is primarily due to patient factors. J Am Soc Nephrol. 2017;28(2):645-652. [CrossRef]
26. Malas MB, Canner JK, Hicks CW, et al. Trends in incident hemodi alysis access and mortality. JAMA Surg. 2015;150(5):441-448. [CrossRef]
27. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995;48(2):510-516. [CrossRef]
28. Pereira GR, Strogoff-de-Matos JP, Ruzany F, et al. Early changes in serum albumin: impact on 2-year mortality in incident hemodialy sis patients. J Bras Nefrol. 2015;37(2):198-205. [CrossRef]
29. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduc tion ratio and serum albumin concentration as predictors of mor tality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001-1006. [CrossRef]
30. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Revisiting mor tality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attr ibutable fraction. Nephrol Dial Transplant. 2005;20(9):1880-1888. [CrossRef]
31. Hao N, Cheng BC, Yang HT, et al. Time-varying serum albumin lev els and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study. BMC Nephrol. 2019;20(1):254. [CrossRef]
32. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictabil ity of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70(4):771-780. [CrossRef]
33. Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guide line for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247-288. [CrossRef]
34. Al Salmi I, Bieber B, Al Rukhaimi M, et al. Parathyroid hormone serum levels and mortality among hemodialysis patients in the Gulf Cooperation Council countries: results from the DOPPS (2012-2018). Kidney360. 2020;1(10):1083-1090. [CrossRef]
35. Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, et al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES study. Nephrol Dial Trans plant. 2011;26(6):1938-1947. [CrossRef]
36. Merle E, Roth H, London GM, et al. Low parathyroid hormone sta tus induced by high dialysate calcium is an independent risk fac tor for cardiovascular death in hemodialysis patients. Kidney Int. 2016;89(3):666-674. [CrossRef]
37. Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodi alysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis. 2001;38(6):1351-1357. [CrossRef]
38. Foley RN, Parfrey PS, Harnett JD, et al. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol. 1996;16(5):386-393. [CrossRef]
39. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflam mation enhances cardiovascular risk and mortality in hemodialy sis patients. Kidney Int. 1999;55(2):648-658. [CrossRef]
40. Kawaguchi T, Tong L, Robinson BM, et al. C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract. 2011;117(2):c167-c178. [CrossRef]
41. Bazeley J, Bieber B, Li Y, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(10):2452-2461. [CrossRef]
42. Salazar J, Martínez MS, Chávez-Castillo M, et al. C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res Not. 2014;2014:653045. [CrossRef]

APA	Erdem E, Karataş A, Ecder T (2023). Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. , 221 - 227. 10.5152/turkjnephrol.2023.2246318
Chicago	Erdem Emre,Karataş Ahmet,Ecder Tevfik Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. (2023): 221 - 227. 10.5152/turkjnephrol.2023.2246318
MLA	Erdem Emre,Karataş Ahmet,Ecder Tevfik Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. , 2023, ss.221 - 227. 10.5152/turkjnephrol.2023.2246318
AMA	Erdem E,Karataş A,Ecder T Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. . 2023; 221 - 227. 10.5152/turkjnephrol.2023.2246318
Vancouver	Erdem E,Karataş A,Ecder T Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. . 2023; 221 - 227. 10.5152/turkjnephrol.2023.2246318
IEEE	Erdem E,Karataş A,Ecder T "Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye." , ss.221 - 227, 2023. 10.5152/turkjnephrol.2023.2246318
ISNAD	Erdem, Emre vd. "Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye". (2023), 221-227. https://doi.org/10.5152/turkjnephrol.2023.2246318

APA	Erdem E, Karataş A, Ecder T (2023). Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. Turkish journal of nephrology (Online), 32(3), 221 - 227. 10.5152/turkjnephrol.2023.2246318
Chicago	Erdem Emre,Karataş Ahmet,Ecder Tevfik Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. Turkish journal of nephrology (Online) 32, no.3 (2023): 221 - 227. 10.5152/turkjnephrol.2023.2246318
MLA	Erdem Emre,Karataş Ahmet,Ecder Tevfik Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. Turkish journal of nephrology (Online), vol.32, no.3, 2023, ss.221 - 227. 10.5152/turkjnephrol.2023.2246318
AMA	Erdem E,Karataş A,Ecder T Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. Turkish journal of nephrology (Online). 2023; 32(3): 221 - 227. 10.5152/turkjnephrol.2023.2246318
Vancouver	Erdem E,Karataş A,Ecder T Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye. Turkish journal of nephrology (Online). 2023; 32(3): 221 - 227. 10.5152/turkjnephrol.2023.2246318
IEEE	Erdem E,Karataş A,Ecder T "Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye." Turkish journal of nephrology (Online), 32, ss.221 - 227, 2023. 10.5152/turkjnephrol.2023.2246318
ISNAD	Erdem, Emre vd. "Risk Factors Affecting 5-Year Mortality in Incident Hemodialysis Patients in the Black Sea Region of Türkiye". Turkish journal of nephrology (Online) 32/3 (2023), 221-227. https://doi.org/10.5152/turkjnephrol.2023.2246318